Silver nanoparticles defeat p53-positive and p53-negative osteosarcoma cells by triggering mitochondrial stress and apoptosis

Citations Over TimeTop 10% of 2016 papers

Abstract

Loss of function of the tumour suppressor p53 observed frequently in human cancers challenges the drug-induced apoptotic elimination of cancer cells from the body. This phenomenon is a major concern and provides much of the impetus for current attempts to develop a new generation of anticancer drugs capable of provoking apoptosis in a p53-independent manner. Since silver nanoparticles (AgNPs) possess unique cytotoxic features, we examined, whether their activity could be exploited to kill tumour suppressor-deficient cancer cells. Therefore, we investigated the effects of AgNPs on osteosarcoma cells of different p53 genetic backgrounds. As particle diameters might influence the molecular mechanisms leading to AgNP-induced cell death we applied 5 nm and 35 nm sized citrate-coated AgNPs. We found that both sized AgNPs targeted mitochondria and induced apoptosis in wild-type p53-containing U2Os and p53-deficient Saos-2 cells. According to our findings AgNPs are able to kill osteosarcoma cells independently from their actual p53 status and induce p53-independent cancer cell apoptosis. This feature renders AgNPs attractive candidates for novel chemotherapeutic approaches.

Related Papers

• → Tumor-Suppressing Effects of miR-141 in Human Osteosarcoma(2013)32 cited
• → Circular RNA circNRIP1 plays oncogenic roles in the progression of osteosarcoma(2021)27 cited
• A experimental study on chemosensitivity to Osteosarcoma in vitro(2013)
• → Atypical Cases of Osteosarcoma.(1991)
• → Diaphyseal osteosarcoma or synchronous osteosarcoma(2020)